Evidence for cholecystokinin-dopamine receptor interactions in the central nervous system of the adult and old rat. Studies on their functional meaning.
Evidence has been presented for the existence of interactions between CCK and DA receptors both in striatal and limbic membranes. A similar type of modulation by CCK-8 of DA receptors also exists after chronic neuroleptic treatment indicating that supersensitive DA receptors are also modulated by this peptide. As seen from simulation curves, CCK-8 increases the binding of [3H]DA agonists and reduces the binding of [3H]DA antagonists in striatal membranes, suggesting that CCK-8 may increase striatal DA transmission. Results of this type may underlie some of the non-neuroleptic effects of CCK-8. In the aged brain, the ability of CCK-8 to modulate DA antagonist binding sites is changed such that the binding of [3H]DA antagonists is increased. Thus, in the aged brain, receptor-receptor interactions may be altered, leading to a derangement of heterostatic mechanisms (mechanisms changing chemical transmission without interfering with synaptic homeostasis). It was also demonstrated that during aging there is a preferential disappearance of CCK-like immunoreactivity versus TH immunoreactivity in the nigral DA neurons, especially in the medially located nigral DA cells; furthermore, co-existence in the TH/CCK co-storing terminals in the nucleus accumbens was reduced during aging. Such alterations should also lead to changes in heterostatic regulation because the CCK co-modulation line controlling the DA receptors may be preferentially affected.
Agnati
L F
LF
Fuxe
K
K
Giardino
L
L
Calza
L
L
Zoli
M
M
Battistini
N
N
Benfenati
F
F
Vanderhaeghen
J J
JJ
Guidolin
D
D
Ruggeri
M
M
D000375:Aging; D000818:Animals; D001058:Apomorphine / Q000031:analogs & derivatives / Q000378:metabolism; D001921:Brain / Q000187:drug effects*; D002766:Cholecystokinin / Q000032:analysis; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D009474:Neurons / Q000032:analysis; D009714:Nucleus Accumbens / Q000032:analysis; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000032:analysis / Q000187:drug effects* / Q000502:physiology; D012844:Sincalide / Q000494:pharmacology* / Q000502:physiology; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis
D011954:Receptors, Dopamine; C009074:N-n-propylnorapomorphine; D002766:Cholecystokinin; D014446:Tyrosine 3-Monooxygenase; D006220:Haloperidol; D012844:Sincalide; D001058:Apomorphine